New $50M Antibiotic Discovery Effort Launched to Combat AMR
The Bill & Melinda Gates Foundation, Novo Nordisk Foundation, and Wellcome have launched a new initiative to develop new antibiotics against gram-negative bacteria. The Gram-Negative Antibiotic Discovery Innovator (Gr-ADI) program aims to address the growing threat of antimicrobial resistance (AMR). With a $50 million budget, Gr-ADI will focus on discovering direct-acting small-molecule antibiotics effective against … Read more